Pfizer
₹3,814+3.20 (+0.08%)as of 2026-10-16
- Market Cap
- ₹17,440Cr.
- P/E Ratio
- 22.7
- P/B Ratio
- 4.15
- EPS (TTM)
- ₹168.02
- Day Range
- ₹3,744 – ₹3,840
- Div Yield
- 1.85%
- ROCE
- 24.1%
- ROE
- 18%
52W Low: ₹3,73152W High: ₹5,446
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 1.0% a year over three years.
- Debt is 0.02× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Pfizer — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 22.7P/E: 22.7 | P/B: 4.15Growth
ModestSales CAGR — 3Y: 1% · 1Y: 11%Profitability
High MarginROCE: 24.1% | ROE: 18%Key Metrics
Valuation
PEG Ratio 2.84
Price / Sales 6.79x
Price / FCF 18.5x
Book Value ₹919
Margins & returns
Operating Margin 37%
Net Margin 28.6%
Return on Assets 14.9%